BRIEF-Health Canada grants approval for Ocaliva By: Reuters: Company News May 25, 2017 at 16:24 PM EDT * Health Canada grants approval for Ocaliva (obeticholic acid) for the treatment of patients with primary biliary cholangitis (pbc) Read More >> Related Stocks: Intercept Pharmaceuticals